MNT speaks with three obesity medicine experts to find out more about the FDA-aproved Wegovy pill and how it's different from the Wegovy injection.

A key to the pill's success will be attracting cash-paying consumers who cannot obtain insurance coverage, a stark shift from the dominant business model.

The FDA-approved weight loss drug offers an oral alternative to invasive injections with similar effectiveness.

The new oral drug costs as little as $149 a month out of pocket and is expected to broaden access as demand for GLP-1 weight-loss treatments grows.

Novo Nordisk’s new Wegovy pill hit the market this week. The Danish drug maker, best known for GLP-1 injections like Ozempic and Wegovy, is now the first company to manufacture and receive FDA approval for an oral GLP-1 pill for weight management.